http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0243521-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42c2b345758f3e5cae104b111c7df90c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1641 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-46 |
| filingDate | 1986-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce9e850e8faa6f6a57f8d7c816c40df7 |
| publicationDate | 1987-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0243521-A1 |
| titleOfInvention | Preparation for oral administration |
| abstract | Orally administrable preparation for humans or animals, containing an active substance which has a side effect damaging the mucous membrane which manifests itself in the formation of plasma polyps, and an auxiliary substance suitable for combating the side effect from the group of intermediate products of glucose breakdown and members of the citrate cycle, preferably sodium pyruvate, characterized in that that the preparation is intended for administration in dissolved form and is in the form of dry storable, readily water-soluble tablets, in which the active substance and the auxiliary substance are contained in the mixture as water-soluble powder and the powder particles are of a solid or semi-solid, storable in the atmosphere, water-soluble, inert and physiologically safe protective substance are largely encased and prevented from reactions with the environment or with each other. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GR-890100182-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100416847-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2628971-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BE-1001706-A3 |
| priorityDate | 1986-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.